TY  - JOUR 
AU  - Escobar, Carlos
AU  - Palacios, Beatriz
AU  - Villarreal, Miriam
AU  - Gutiérrez, Martín
AU  - Capel, Margarita
AU  - Hernández, Ignacio
AU  - García, María
AU  - Lledó, Laura
AU  - Arenillas Lara, Juan Francisco
PY  - 2024
UR  - https://uvadoc.uva.es/handle/10324/70208
AB  - Objective. To analyze the clinical characteristics of patients taking Factor Xa inhibitors (FXai), either direct FXai or enoxaparin (only in active cancer patients), and to estimate the incidence of and risk factors for major bleeding during FXai use....
LA  - eng
PB  - MDPI
KW  - Anticoagulants (Medicine)
KW  - Anticoagulantes
KW  - Hemorrhage - Treatment
KW  - Hemorragia - Tratamiento
KW  - Brain - Hemorrhage
KW  - Cerebro - Hemorragia
KW  - Cerebrovascular disease
KW  - Cerebro - Vasos sanguineos - Enfermedades
KW  - Gastrointestinal hemorrhage
KW  - Digestivo, Aparato - Hemorragia
KW  - Cardiology
KW  - Pharmacology
KW  - Hematology
KW  - Neurology
KW  - Clinical Medicine
KW  - Public health - Spain
KW  - Salud pública - España
TI  - Clinical characteristics and incidence of hemorrhagic complications in patients taking factor Xa inhibitors in Spain: a long-term observational study
DO  - 10.3390/jcm13061677
ER  -